People s United Financial Inc. Trims Stock Holdings in West Pharmaceutical Services, Inc. (NYSE:WST)

People s United Financial Inc. reduced its position in West Pharmaceutical Services, Inc. (NYSE:WSTGet Rating) by 15.0% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,617 shares of the medical instruments supplier’s stock after selling 812 shares during the quarter. People s United Financial Inc.’s holdings in West Pharmaceutical Services were worth $1,896,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the company. BlackRock Inc. boosted its position in shares of West Pharmaceutical Services by 8.9% in the fourth quarter. BlackRock Inc. now owns 8,094,288 shares of the medical instruments supplier’s stock valued at $3,796,302,000 after acquiring an additional 664,275 shares during the period. State Street Corp boosted its position in shares of West Pharmaceutical Services by 1.6% in the fourth quarter. State Street Corp now owns 3,455,709 shares of the medical instruments supplier’s stock valued at $1,620,762,000 after acquiring an additional 54,510 shares during the period. WCM Investment Management LLC boosted its position in shares of West Pharmaceutical Services by 0.8% in the first quarter. WCM Investment Management LLC now owns 1,526,481 shares of the medical instruments supplier’s stock valued at $626,941,000 after acquiring an additional 11,655 shares during the period. Geode Capital Management LLC boosted its position in shares of West Pharmaceutical Services by 3.0% in the fourth quarter. Geode Capital Management LLC now owns 1,382,016 shares of the medical instruments supplier’s stock valued at $646,546,000 after acquiring an additional 40,280 shares during the period. Finally, Northern Trust Corp lifted its position in West Pharmaceutical Services by 0.5% during the fourth quarter. Northern Trust Corp now owns 970,724 shares of the medical instruments supplier’s stock valued at $455,279,000 after purchasing an additional 5,206 shares during the last quarter. 93.25% of the stock is currently owned by institutional investors.

West Pharmaceutical Services Trading Down 0.0 %

Shares of West Pharmaceutical Services stock opened at $340.82 on Tuesday. West Pharmaceutical Services, Inc. has a 1 year low of $275.89 and a 1 year high of $475.35. The firm has a market cap of $25.24 billion, a PE ratio of 37.83, a PEG ratio of 1.38 and a beta of 1.15. The company has a debt-to-equity ratio of 0.09, a current ratio of 3.13 and a quick ratio of 2.41. The company has a 50 day simple moving average of $311.62 and a two-hundred day simple moving average of $345.42.

West Pharmaceutical Services (NYSE:WSTGet Rating) last announced its earnings results on Thursday, July 28th. The medical instruments supplier reported $2.47 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.19 by $0.28. West Pharmaceutical Services had a net margin of 23.41% and a return on equity of 29.08%. The business had revenue of $771.30 million during the quarter, compared to analyst estimates of $754.25 million. During the same period in the previous year, the business posted $2.46 earnings per share. West Pharmaceutical Services’s revenue for the quarter was up 6.6% on a year-over-year basis. Analysts expect that West Pharmaceutical Services, Inc. will post 9.1 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other West Pharmaceutical Services news, insider Silji Abraham sold 5,374 shares of West Pharmaceutical Services stock in a transaction that occurred on Monday, August 1st. The shares were sold at an average price of $343.93, for a total transaction of $1,848,279.82. Following the transaction, the insider now directly owns 3,201 shares of the company’s stock, valued at $1,100,919.93. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.60% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, StockNews.com lowered shares of West Pharmaceutical Services from a “buy” rating to a “hold” rating in a research report on Thursday, April 28th.

About West Pharmaceutical Services

(Get Rating)

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.

See Also

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.